Document Detail


Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer.
MedLine Citation:
PMID:  17189524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Local growth, invasion, and metastasis of malignancies of the head and neck involve extensive degradation and remodeling of the underlying, collagen-rich connective tissue. Urokinase plasminogen activator receptor-associated protein (uPARAP)/Endo180 is an endocytic receptor recently shown to play a critical role in the uptake and intracellular degradation of collagen by mesenchymal cells. As a step toward determining the putative function of uPARAP/Endo180 in head and neck cancer progression, we used immunohistochemistry to determine the expression of this collagen internalization receptor in 112 human squamous cell carcinomas and 19 normal or tumor-adjacent head and neck tissue samples from the tongue, gingiva, cheek, tonsils, palate, floor of mouth, larynx, maxillary sinus, upper jaw, nasopharynx/nasal cavity, and lymph nodes. Specificity of detection was verified by staining of serial sections with two different monoclonal antibodies against two non-overlapping epitopes on uPARAP/Endo180 and by the use of isotype-matched non-immune antibodies. uPARAP/Endo180 expression was observed in stromal fibroblast-like, vimentin-positive cells. Furthermore, expression of the collagen internalization receptor was increased in tumor stroma compared with tumor-adjacent connective tissue or normal submucosal connective tissue and was most prominent in poorly differentiated tumors. These data suggest that uPARAP/Endo180 participates in the connective tissue destruction during head and neck squamous cell carcinoma progression by mediating cellular uptake and lysosomal degradation of collagen.
Authors:
Jay Sulek; Rebecca A Wagenaar-Miller; Jessica Shireman; Alfredo Molinolo; Daniel H Madsen; Lars H Engelholm; Niels Behrendt; Thomas H Bugge
Related Documents :
14530304 - The molecular biology of mucosal field cancerization of the head and neck.
3108804 - Expression of a9 antigen and loss of blood group antigens as determinants of survival i...
18519704 - Involvement of rac in fenretinide-induced apoptosis.
8284754 - Malignant mixed tumor (carcinosarcoma) of the pancreas: a case report supporting organ-...
22323494 - Rationale behind targeting fibroblast activation protein-expressing carcinoma-associate...
22084164 - Vascular disruption in combination with mtor inhibition in renal cell carcinoma.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2006-12-22
Journal Detail:
Title:  The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society     Volume:  55     ISSN:  0022-1554     ISO Abbreviation:  J. Histochem. Cytochem.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-03-19     Completed Date:  2007-05-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815334     Medline TA:  J Histochem Cytochem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  347-53     Citation Subset:  IM    
Affiliation:
Oral & Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blotting, Western
Carcinoma, Squamous Cell / metabolism*,  pathology
Disease Progression
Head and Neck Neoplasms / metabolism*,  pathology
Humans
Immunohistochemistry
Receptors, Mitogen / biosynthesis*
Chemical
Reg. No./Substance:
0/Endo180; 0/Receptors, Mitogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of Smad ubiquitin regulatory factor 2 (Smurf2) in rhesus monkey endometrium and placenta ...
Next Document:  Expression profiles of mouse Kell, XK, and XPLAC mRNA.